European Market Report for Endometrial Resection Devices
|出版商||iData Research Inc.||商品編碼||371081|
|出版日期||內容資訊||英文 86 Pages
|歐洲的子宮內膜切除設備市場分析 European Market Report for Endometrial Resection Devices|
|出版日期: 2016年09月01日||內容資訊: 英文 86 Pages||
As patients are opting for alternative treatment options, the remaining endometrial resection procedures being performed are utilizing superior bipolar loop electrodes.
Electrosurgical rollerballs are often used in conjunction with endometrial loop electrodes. Italy and Spain have the highest unit numbers sold per year, using one electrosurgical rollerball unit per every three to four patients treated. In contrast, France and the Scandinavia region have the lowest sales, only using one electrosurgical rollerball for one to two out of every ten patients treated.
The resectoscope market unit sales are deceptively positive with a neutral growth despite the decline in the number of procedures being performed. This is because the resectoscope market is a replacement market, with current sales replacing monopolar resectoscopes and upgrading to purchase bipolar resectoscopes. The future trend is a stable to modest decline in sales as fewer endometrial resection procedures are performed.
While global endometrial ablation is a popular treatment for menorrhagia, another common treatment is endometrial resection. This is performed as a hysteroscopic procedure and uses a resectoscope and an electrosurgical loop electrode to remove the endometrial lining. This procedure is done as an alternative to a hysterectomy for treatment of menorrhagia or heavy bleeding. Heavy bleeding is sometimes referred to as 80mL or more per menstrual cycle, which can interfere with a woman's daily life. Endometrial resection is appropriate for women who have pure menorrhagia but no other additional abnormalities, such as endometriosis, endometrial hyperplasia or very large or rapidly growing fibroids. Many patients of endometrial resection, in addition to having a reduction of menorrhagia symptoms, also experience a reduction in other symptoms related to premenstrual syndrome (PMS).